首页> 外文OA文献 >Can serum HBV-DNA be used as a primary end point to assess efficacy of new treatments for chronic hepatitis B?

【2h】

Can serum HBV-DNA be used as a primary end point to assess efficacy of new treatments for chronic hepatitis B?

机译：血清HBV-DNA可以作为评估慢性乙肝新疗法疗效的主要终点吗？

页面导航

著录项
相似文献
相关主题

著录项

作者
Alberti A;
展开▼
作者单位

展开▼
年度 2003
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA [J] . Martinot-PeignouxM., LapalusM., LaouénanC., Journal of clinical virology: The official publication of the Pan American Society for Clinical Virology . 2013,第2期

机译：使用基线血清HBsAg和HBV-DNA的测定预测无症状乙型肝炎e抗原阴性的慢性乙型肝炎患者的疾病恢复
2. Combined branched-DNA and conventional HBV PCR assays for detection of serum HBV-DNA in hepatitis B e antigen-positive chronic hepatitis B patients. [J] . Ozdarendeli A, Toroman ZA, Bulut Y, Hepato-gastroenterology. . 2006,第67期

机译：结合的分支DNA和常规HBV PCR分析方法可检测乙型肝炎e抗原阳性的慢性乙型肝炎患者的血清HBV-DNA。
3. Comparison of serum hepatitis B virus replication markers in patients with chronic hepatitis B: studies on HBeAg/Anti-HBe system, viral dna polymerase and HBV-DNA [J] . Celso Francisco Hernandes Granato, Flair José Carrilho, Jo?o Renato Rebello Pinho, Revista do Instituto de Medicina Tropical de So Paulo . 1989,第5期

机译：慢性乙型肝炎患者血清乙型肝炎病毒复制标志物的比较：HBeAg / Anti-HBe系统，病毒DNA聚合酶和HBV-DNA的研究
4. Negative Effect of IFN-onα2b against HBV-DNA in PBMC, Serum and Inducement to CD25 in the Patients with Chronic Hepatitis B [C] . WANG Jian, SUN Lin, XIANG Gui-ju, 2009 IEEE International Symposium on IT in Medicine Education( IEEE 教育与医药信息化国际会议）论文集 . 2009

机译：慢性乙型肝炎患者IFN-α2b对PBMC HBV-DNA，血清和CD25诱导的负面影响
5. Immune Responses During Resolution of Acute Hepatitis B in Woodchucks and Their Modulation for Treatment of Chronic Hepatitis B [D] . Suresh, Manasa. 2020

机译：桃毛急性乙型肝炎分辨率的免疫反应及其治疗慢性乙型肝炎
6. Analysis of the molecular state of HBV-DNA in the liver and serum of patients with chronic hepatitis or primary liver cell carcinoma and the effect of therapy with adenine arabinoside. [O] . M J Fowler, J Monjardino, I V Weller, 1984

机译：慢性肝炎或原发性肝细胞癌患者肝和血清中HBV-DNA的分子状态分析以及腺嘌呤阿拉伯糖苷治疗的效果。
7. Comparison of serum hepatitis B virus replication markers in patients with chronic hepatitis B: studies on HBeAg/Anti-HBe system, viral dna polymerase and HBV-DNA Comparação dos marcadores sorológicos da replicação do vírus da hepatite B: estudos sobre o sistema AgHBe/anti-HBe, DNA polimerase virai e HBV-DNA [O] . João Renato Rebello Pinho, Luís Edmundo Pinto da Fonseca, Yu Song, 1989

机译：慢性乙型肝炎患者血清乙型肝炎病毒复制标志物的比较：HBeag /抗HBe系统，病毒dna聚合酶和HBV-DNa的研究乙型肝炎病毒复制血清学标志物的比较：agHBe /抗体系研究HBe，病毒DNa聚合酶和HBV-DNa

Can serum HBV-DNA be used as a primary end point to assess efficacy of new treatments for chronic hepatitis B?

著录项

相似文献

相关主题

期刊订阅